HP
ATRS

HealthInvest Partners’s Antares Pharma, Inc. ATRS Stock Holding History

HealthInvest Partners’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,720,000
Closed -$6.86M – 20
2020
Q4 		$6.86M Buy
+1,720,000
New +$5.56M 4.55% 15

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

HealthInvest Partners's ATRS Position: Q1 2021 in Review

HealthInvest Partners sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 1,720,000 shares — an estimated $6.86M sold.

HealthInvest Partners first reported a position in ATRS in Q4 2020 and held it in 1 quarter. The position peaked at $6.86M in Q4 2020. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • HealthInvest Partners reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • HealthInvest Partners sold 1,720,000 Antares Pharma, Inc. shares in Q1 2021, an estimated $6.86M.
  • HealthInvest Partners first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 1 quarter.
  • HealthInvest Partners's Antares Pharma, Inc. position peaked at $6.86M in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on HealthInvest Partners's 13F filing for Q1 2021, filed 30 Apr 2021.